Insider track record
OtherNot enough buy signals with a settled T+90 horizon to measure a track record yet.
Explore the full record of transactions filed by Hudson Susan Claire. Officer active across 1 company, notably Flowserve CORP. Cumulatively, 21 filings have been recorded. Breakdown: 0 buy · 1 sell. Total volume traded: €648k. History available since 15 February 2023. The latest transaction was filed on 3 August 2026 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Hudson Susan Claire
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations21 total
48 shares@ US$75.99Common StockSEC:0001628280-26-051896:0
32 shares@ US$75.510.0000% mcap100.0% of flowCommon StockSEC:0001628280-26-039510:0
33 shares@ US$73.640.0000% mcap49.9% of flowCommon StockSEC:0001628280-26-029430:0
31 shares@ US$73.5132.1% of flowCommon StockSEC:0001628280-26-022811:0
3,300 shares0Common StockSEC:0001628280-26-014686:0
3,296 shares0Common StockSEC:0001628280-26-009077:0
21,242 shares0Common StockSEC:0001628280-26-008629:0
10,667 shares@ US$70.0199.1% of flowCommon StockSEC:0001628280-25-049688:0
751 shares0Common StockSEC:0001628280-25-027943:0
260 shares@ US$49.611.7% of flowCommon StockSEC:0001628280-25-027943:1
3,250 shares0Common StockSEC:0000030625-25-000048:0
1,372 shares0Common StockSEC:0000030625-25-000027:0
4,642 shares0Common StockSEC:0000030625-25-000014:0
737 shares0Common StockSEC:0000030625-24-000076:0
1,348 shares0Common StockSEC:0000030625-24-000032:0
723 shares0Common StockSEC:0000030625-23-000100:0
1,320 shares0Common StockSEC:0000030625-23-000070:0
1,047 shares0Common StockSEC:0000030625-23-000061:0
512 shares0Common StockSEC:0000030625-23-000036:0
1,047 shares0Common StockSEC:0000030625-23-000027:0
1,320 shares0Common StockSEC:0000030625-23-000012:0
About Hudson Susan Claire
Hudson Susan Claire has 20 filings in total. Across the 20 recent filings available, all for Flowserve CORP, sales total EUR 648309 and the period runs from 2023-02-17 to 2026-06-01. The stated transaction nature is option exercise.